CLINICAL_TRIALS
trial_result
· 2021-07-07
Clinical Trial Update: Bexagliflozin Efficacy and Safety Trial [Phase 3]
Summary
Phase 3 trial update for Bexagliflozin evaluating efficacy and safety in Type 2 Diabetes Mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Theracos | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2021-07-07